Publikationen zum Thema Übergewichtschirurgie

Doz. Dr. Arthur Bohdjalian – Wien

Nachfolgend finden Sie eine Auflistung von Veröffentlichungen zum Thema Übergewichtschirurgie, an denen Dr. Arthur Bohdjalian mitgewirkt hat. Der Zeitraum der Veröffentlichungen erstreckt sich über die Jahre von 2003 bis 2015. Ein Anspruch auf Vollständigkeit der Auflistung besteht nicht.

1. Surgical Elimination of the Gastric Digestion by Roux-en-Y Gastric Bypass Impacts on Food Sensitisation-a Pilot Study. Shakeri-Leidenmühler S, Lukschal A, Schultz C, Bohdjalian A, Langer F, Birsan T, Diesner SC, Greisenegger EK, Scheiner O, Kopp T, Jensen-Jarolim E, Prager G, Untersmayr E.
   Obes Surg. 2015 Dec;25(12):2268-75. doi: 10.1007/s11695-015-1689-4.
   PMID: 25910982
2. Post-Bariatric Body-Contouring Surgery: Fewer Procedures, Less Demand, and Lower Costs. Felberbauer FX, Shakeri-Leidenmühler S, Langer FB, Kitzinger H, Bohdjalian A, Kefurt R, Prager G.
   Obes Surg. 2015 Jul;25(7):1198-202. doi: 10.1007/s11695-014-1493-6.
   PMID: 25491913
3. Weight loss and weight regain-5-year follow-up for circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Langer FB, Prager G, Poglitsch M, Kefurt R, Shakeri-Leidenmühler S, Ludvik B, Schindler K, Bohdjalian A.
   Obes Surg. 2013 Jun;23(6):776-81. doi: 10.1007/s11695-013-0892-4.
   PMID: 23483356
4. Single-stage operative management of laparoscopic sleeve gastrectomy leaks without endoscopic stent placement. El Hassan E, Mohamed A, Ibrahim M, Margarita M, Al Hadad M, Nimeri AA.
   Obes Surg. 2013 May;23(5):722-6. doi: 10.1007/s11695-013-0906-2.
   PMID: 23460264
5. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Itariu BK, Zeyda M, Hochbrugger EE, Neuhofer A, Prager G, Schindler K, Bohdjalian A, Mascher D, Vangala S, Schranz M, Krebs M, Bischof MG, Stulnig TM.
   Am J Clin Nutr. 2012 Nov;96(5):1137-49. doi: 10.3945/ajcn.112.037432. Epub 2012 Oct 3.
   PMID: 23034965
6. Gastric stimulation in the digestive period modifies length and contractility of the inter-digestive period in obese non-diabetic and diabetic subjects. Bohdjalian A, Aviv R, Prager G, Schindler K, Bacher E, Langer F, Ludvik B.
   Obes Surg. 2012 Sep;22(9):1465-72. doi: 10.1007/s11695-012-0703-3.
   PMID: 22761022
7. After massive weight loss: patients’ expectations of body contouring surgery. Kitzinger HB, Abayev S, Pittermann A, Karle B, Bohdjalian A, Langer FB, Prager G, Frey M.
   Obes Surg. 2012 Apr;22(4):544-8. doi: 10.1007/s11695-011-0551-6.
   PMID: 22101887
8. The prevalence of body contouring surgery after gastric bypass surgery. Kitzinger HB, Abayev S, Pittermann A, Karle B, Kubiena H, Bohdjalian A, Langer FB, Prager G, Frey M.
   Obes Surg. 2012 Jan;22(1):8-12. doi: 10.1007/s11695-011-0459-1.
   PMID: 21643778
9. Strategies for weight regain after sleeve gastrectomy. Langer FB, Shakeri-Leidenmühler S, Bohdjalian A, Schoppmann S, Zacherl J, Felberbauer FX, Vila G, Prager G.
   Surg Laparosc Endosc Percutan Tech. 2010 Jun;20(3):159-61. doi: 10.1097/SLE.0b013e3181e24f3b. Review. No abstract available.
   PMID: 20551813
10. Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass–indications and outcome. Langer FB, Bohdjalian A, Shakeri-Leidenmühler S, Schoppmann SF, Zacherl J, Prager G.
    Obes Surg. 2010 Jul;20(7):835-40. doi: 10.1007/s11695-010-0125-z.
    PMID: 20393810
11. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, Gfrerer L, Ludvik B, Zacherl J, Prager G.
    Obes Surg. 2010 May;20(5):535-40. doi: 10.1007/s11695-009-0066-6. Epub 2010 Jan 22.
    PMID: 20094819
12. Circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Bohdjalian A, Langer FB, Kranner A, Shakeri-Leidenmühler S, Zacherl J, Prager G.
    Obes Surg. 2010 Apr;20(4):440-6. doi: 10.1007/s11695-009-9998-0. Epub 2009 Oct 24.
    PMID: 19856035
13. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Bohdjalian A, Prager G, Rosak C, Weiner R, Jung R, Schramm M, Aviv R, Schindler K, Haddad W, Rosenthal N, Ludvik B.
    Obes Surg. 2009 Sep;19(9):1221-7. doi: 10.1007/s11695-009-9901-z. Epub 2009 Jul 3.
    PMID: 19575272
14. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Bohdjalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, Karnieli E, Assalia A, Prager R, Prager G.
    Surg Endosc. 2009 Sep;23(9):1955-60. doi: 10.1007/s00464-008-0222-4. Epub 2008 Dec 6.
    PMID: 19067068
15. Lymphocyte activation and correlation with IMPDH activity under therapy with mycophenolate mofetil. Devyatko E, Dunkler D, Bohdjalian A, Zuckermann A, Grimm M, Muehlbacher F, Weigel G.
    Clin Chim Acta. 2008 Aug;394(1-2):67-71. doi: 10.1016/j.cca.2008.04.006. Epub 2008 Apr 12.
    PMID: 18474232
16. Inadequate weight loss vs secondary weight regain: laparoscopic conversion from gastric banding to Roux-en-Y gastric bypass. Langer FB, Bohdjalian A, Shakeri-Manesch S, Felberbauer FX, Ludvik B, Zacherl J, Prager G.
    Obes Surg. 2008 Nov;18(11):1381-6. doi: 10.1007/s11695-008-9479-x. Epub 2008 Apr 26.
    PMID: 18438619
17. Cardiopulmonary resuscitation-associated major liver injury. Meron G, Kurkciyan I, Sterz F, Susani M, Domanovits H, Tobler K, Bohdjalian A, Laggner AN.
    Resuscitation. 2007 Dec;75(3):445-53. Epub 2007 Jul 20.
    PMID: 17640792
18. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Haider DG, Schindler K, Bohdjalian A, Prager G, Luger A, Wolzt M, Ludvik B.
    Diabetes Obes Metab. 2007 Sep;9(5):761-3. Epub 2007 Mar 13.
    PMID: 17359244
19. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B.
    J Clin Endocrinol Metab. 2007 Mar;92(3):1168-71. Epub 2006 Dec 12.
    PMID: 17164313
20. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil. Devyatko E, Zuckermann A, Bohdjalian A, Roedler S, Dunkler D, Grimm M, Weigel G.
    Transplantation. 2006 Jul 15;82(1):113-8.
    PMID: 16861950
21. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, Riener R, Zacherl J, Ludvik B.
    Obes Surg. 2006 May;16(5):627-34.
    PMID: 16687033
22. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, Zacherl J, Jakesz R, Prager G.
    Obes Surg. 2006 Feb;16(2):166-71.
    PMID: 16469218
23. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, Schindler K, Luger A, Ludvik B, Prager G.
    Obes Surg. 2005 Aug;15(7):1024-9.
    PMID: 16105401
24. Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation. Devyatko E, Zuckermann A, Ruzicka M, Bohdjalian A, Wieselthaler G, Rödler S, Wolner E, Grimm M.
    J Heart Lung Transplant. 2004 Nov;23(11):1277-82.
    PMID: 15539126
25. Surgical treatment of obesity. Bohdjalian A, Langer F, Reza Hoda MA, Felberbauer F, Silberhumer G, Zacherl J, Schindler K, Luger A, Ludvik B, Prager G.
    Wien Med Wochenschr. 2004 Jul;154(13-14):329-33. Review. German.
    PMID: 15368954
26. The University of Vienna experience in heart transplantation. Zuckermann A, Bohdjalian A, Deviatko E, Dunkler D, Rödler S, Ehrlich M, Wieselthaler G, Pacher R, Bunzel B, Wollenek G, Laczkovics A, Laufer G, Wolner E, Grimm M.
    Clin Transpl. 2002:229-42.
    PMID: 12971454
27. Predictors of adverse outcome and transient neurological dysfunction following surgical treatment of acute type A dissections. Ehrlich MP, Schillinger M, Grabenwöger M, Kocher A, Tschernko EM, Simon P, Bohdjalian A, Wolner E.
    Circulation. 2003 Sep 9;108 Suppl 1:II318-23.
    PMID: 12970253
28. Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Zuckermann A, Dunkler D, Deviatko E, Bohdjalian A, Czerny M, Ankersmit J, Wolner E, Grimm M.
    Eur J Cardiothorac Surg. 2003 Aug;24(2):283-91; discussion 291.
    PubMed PMID: 12895621